Top

Journal of Cardiovascular Translational Research

Published in:

01-10-2011

Stem Cell-Based Cardiac Tissue Engineering

Authors: Sara S. Nunes, Hannah Song, C. Katherine Chiang, Milica Radisic

Published in: Journal of Cardiovascular Translational Research | Issue 5/2011

Abstract

Cardiovascular diseases are the leading cause of death worldwide, and cell-based therapies represent a potential cure for patients with cardiac diseases such as myocardial infarction, heart failure, and congenital heart diseases. Towards this goal, cardiac tissue engineering is now being investigated as an approach to support cell-based therapies and enhance their efficacy. This review focuses on the latest research in cardiac tissue engineering based on the use of embryonic, induced pluripotent, or adult stem cells. We describe different strategies such as direct injection of cells and/or biomaterials as well as direct replacement therapies with tissue mimics. In this regard, the latest research has shown promising results demonstrating the improvement of cardiac function with different strategies. It is clear from recent studies that the most important consideration to be addressed by new therapeutic strategies is long-term functional improvement. For this goal to be realized, novel and efficient methods of cell delivery are required that enable high cell retention, followed by electrical integration and mechanical coupling of the injected cells or the engineered tissue to the host myocardium.

Boilson, B. A., et al. (2010). Device therapy and cardiac transplantation for end-stage heart failure. Current Problems in Cardiology, 35(1), 8–64.PubMedCrossRef

Kirkpatrick, J. N., Wiegers, S. E., & Lang, R. M. (2010). Left ventricular assist devices and other devices for end-stage heart failure: utility of echocardiography. Current Cardiology Reports, 12(3), 257–264.PubMedCrossRef

Nelson, T. J., Behfar, A., & Terzic, A. (2008). Strategies for therapeutic repair: The “R3” regenerative medicine paradigm. Clinical and Translational Science, 1(2), 168–171.PubMedCrossRef

Murry, C. E., Reinecke, H., & Pabon, L. M. (2006). Regeneration gaps: Observations on stem cells and cardiac repair. Journal of the American College of Cardiology, 47(9), 1777–1785.PubMedCrossRef

Rossini, R., et al. (2010). Prevention of left ventricular remodelling after acute myocardial infarction: An update. Recent Patents on Cardiovascular Drug Discovery, 5(3), 196–207.PubMedCrossRef

Radisic, M., et al. (2008). Cardiac tissue engineering using perfusion bioreactor systems. Nature Protocols, 3(4), 719–738.PubMedCrossRef

Reinecke, H., et al. (1999). Survival, integration, and differentiation of cardiomyocyte grafts: A study in normal and injured rat hearts. Circulation, 100(2), 193–202.PubMed

Herrmann, J. L., et al. (2009). Cell-based therapy for ischemic heart disease: A clinical update. The Annals of Thoracic Surgery, 88(5), 1714–1722.PubMedCrossRef

Yoon, S. J., et al. (2009). Regeneration of ischemic heart using hyaluronic acid-based injectable hydrogel. Journal of Biomedical Materials Research. Part B, Applied Biomaterials, 91(1), 163–171.PubMedCrossRef

10.

Singelyn, J. M., & Christman, K. L. (2010). Injectable materials for the treatment of myocardial infarction and heart failure: The promise of decellularized matrices. Journal of Cardiovascular Translational Research, 3(5), 478–486.PubMedCrossRef

11.

Christoforou, N., et al. (2010). Implantation of mouse embryonic stem cell-derived cardiac progenitor cells preserves function of infarcted murine hearts. PloS One, 5(7), e11536.PubMedCrossRef

12.

Adler, E. D., et al. (2010). The cardiomyocyte lineage is critical for optimization of stem cell therapy in a mouse model of myocardial infarction. The FASEB Journal, 24(4), 1073–1081.PubMedCrossRef

13.

Caspi, O., et al. (2007). Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. Journal of the American College of Cardiology, 50(19), 1884–1893.PubMedCrossRef

14.

Fernandes, S., et al. (2010). Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats. Journal of Molecular and Cellular Cardiology, 49(6), 941–949.PubMedCrossRef

15.

Laflamme, M. A., et al. (2007). Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nature Biotechnology, 25(9), 1015–1024.PubMedCrossRef

16.

van Laake, L. W., et al. (2009). Improvement of mouse cardiac function by hESC-derived cardiomyocytes correlates with vascularity but not graft size. Stem Cell Research, 3(2–3), 106–112.PubMedCrossRef

17.

Nelson, T. J., et al. (2009). Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation, 120(5), 408–416.PubMedCrossRef

18.

Lu, W. N., et al. (2009). Functional improvement of infarcted heart by co-injection of embryonic stem cells with temperature-responsive chitosan hydrogel. Tissue Engineering. Part A, 15(6), 1437–1447.PubMedCrossRef

19.

Fujimoto, K. L., et al. (2009). Naive rat amnion-derived cell transplantation improved left ventricular function and reduced myocardial scar of postinfarcted heart. Cell Transplantation, 18(4), 477–486.PubMedCrossRef

20.

Smits, A. M., et al. (2009). Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium. Cardiovascular Research, 83(3), 527–535.PubMedCrossRef

21.

Landa, N., et al. (2008). Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation, 117(11), 1388–1396.PubMedCrossRef

22.

Wall, S. T., et al. (2010). Biomimetic matrices for myocardial stabilization and stem cell transplantation. Journal of Biomedical Materials Research. Part A, 95(4), 1055–1066.PubMedCrossRef

23.

Dengler, J., et al. (2010). Engineered heart tissue enables study of residual undifferentiated embryonic stem cell activity in a cardiac environment. Biotechnol Bioeng, 108, 704–719.PubMedCrossRef

24.

Hansen, A., et al. (2010). Development of a drug screening platform based on engineered heart tissue. Circulation Research, 107(1), 35–44.PubMedCrossRef

25.

Passier, R., van Laake, L. W., & Mummery, C. L. (2008). Stem-cell-based therapy and lessons from the heart. Nature, 453(7193), 322–329.PubMedCrossRef

26.

Segers, V. F. M., & Lee, R. T. (2008). Stem-cell therapy for cardiac disease. Nature, 451(7181), 937–942.PubMedCrossRef

27.

Gnecchi, M., et al. (2005). Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nature Medicine, 11(4), 367–368.PubMedCrossRef

28.

Jawad, H., et al. (2007). Myocardial tissue engineering: A review. Journal of Tissue Engineering and Regenerative Medicine, 1(5), 327–342.PubMedCrossRef

29.

De Falco, M., Cobellis, G., & De Luca, A. (2009). Proliferation of cardiomyocytes: A question unresolved. Frontiers in Bioscience (Elite Ed), 1, 528–536.

30.

Thomson, J. A., et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282(5391), 1145–1147.PubMedCrossRef

31.

Stevens, K. R., et al. (2009). Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue. Proceedings of the National Academy of Sciences of the United States of America, 106(39), 16568–16573.PubMedCrossRef

32.

Stevens, K. R., et al. (2009). Scaffold-free human cardiac tissue patch created from embryonic stem cells. Tissue Engineering. Part A, 15(6), 1211–1222.PubMedCrossRef

33.

Kreutziger, K. L., & Murry, C. E. (2011). Engineered human cardiac tissue. Pediatr Cardiol, 32, 334–341.PubMedCrossRef

34.

Ke, Q., et al. (2005). Embryonic stem cells cultured in biodegradable scaffold repair infarcted myocardium in mice. Sheng Li Xue Bao, 57(6), 673–681.PubMed

35.

Nussbaum, J., et al. (2007). Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. The FASEB Journal, 21(7), 1345–1357.PubMedCrossRef

36.

Chen, Q. Z., et al. (2010). An elastomeric patch derived from poly(glycerol sebacate) for delivery of embryonic stem cells to the heart. Biomaterials, 31(14), 3885–3893.PubMedCrossRef

37.

Engelmayr, G. C., Jr., et al. (2008). Accordion-like honeycombs for tissue engineering of cardiac anisotropy. Nature Materials, 7(12), 1003–1010.PubMedCrossRef

38.

Guo, X. M., et al. (2006). Creation of engineered cardiac tissue in vitro from mouse embryonic stem cells. Circulation, 113(18), 2229–2237.PubMedCrossRef

39.

Gwak, S. J., et al. (2008). The effect of cyclic strain on embryonic stem cell-derived cardiomyocytes. Biomaterials, 29(7), 844–856.PubMedCrossRef

40.

Boyd, N. L., et al. (2011). Microvascular mural cell functionality of human embryonic stem cell-derived mesenchymal cells. Tissue Eng Part A, 15, 1897–1907.CrossRef

41.

Ferreira, L. S., et al. (2007). Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle like cells and form vascular networks in vivo. Circulation Research, 101(3), 286–294.PubMedCrossRef

42.

Levenberg, S., et al. (2002). Endothelial cells derived from human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 99(7), 4391–4396.PubMedCrossRef

43.

Kraehenbuehl, T. P., et al. (2010). Human embryonic stem cell-derived microvascular grafts for cardiac tissue preservation after myocardial infarction. Biomaterials, 32(4), 1102–1109.PubMedCrossRef

44.

Caspi, O., et al. (2007). Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circulation Research, 100(2), 263–272.PubMedCrossRef

45.

Lesman, A., et al. (2010). Transplantation of a tissue-engineered human vascularized cardiac muscle. Tissue Engineering. Part A, 16(1), 115–125.PubMedCrossRef

46.

Zhang, J., et al. (2009). Functional cardiomyocytes derived from human induced pluripotent stem cells. Circulation Research, 104(4), e30–e41.PubMedCrossRef

47.

Deb, A., et al. (2003). Bone marrow-derived cardiomyocytes are present in adult human heart: A study of gender-mismatched bone marrow transplantation patients. Circulation, 107(9), 1247–1249.PubMedCrossRef

48.

Jackson, K. A., et al. (2001). Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. The Journal of Clinical Investigation, 107(11), 1395–1402.PubMedCrossRef

49.

Orlic, D., et al. (2003). Bone marrow stem cells regenerate infarcted myocardium. Pediatric Transplantation, 7(Suppl 3), 86–88.PubMedCrossRef

50.

Orlic, D., et al. (2001). Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proceedings of the National Academy of Sciences of the United States of America, 98(18), 10344–10349.PubMedCrossRef

51.

Rosenzweig, A. (2006). Cardiac cell therapy—mixed results from mixed cells. The New England Journal of Medicine, 355(12), 1274–1277.PubMedCrossRef

52.

Oh, H., et al. (2003). Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proceedings of the National Academy of Sciences of the United States of America, 100(21), 12313–12318.PubMedCrossRef

53.

Beltrami, A. P., et al. (2003). Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell, 114(6), 763–776.PubMedCrossRef

54.

Laugwitz, K. L., et al. (2005). Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature, 433(7026), 647–653.PubMedCrossRef

55.

Domian, I. J., et al. (2009). Generation of functional ventricular heart muscle from mouse ventricular progenitor cells. Science, 326(5951), 426–429.PubMedCrossRef

56.

Johnston, P. V., et al. (2009). Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy. Circulation, 120(12), 1075–1083. 7 p following 1083.PubMedCrossRef

57.

Messina, E., et al. (2004). Isolation and expansion of adult cardiac stem cells from human and murine heart. Circulation Research, 95(9), 911–921.PubMedCrossRef

58.

Chimenti, I., et al. (2010). Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circulation Research, 106(5), 971–980.PubMedCrossRef

59.

Cheng, K., et al. (2010). Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction. Circulation Research, 106(10), 1570–1581.PubMedCrossRef

60.

Alper, J. (2009). Geron gets green light for human trial of ES cell-derived product. Nat Biotech, 27(3), 213–214.CrossRef

61.

Chen, S. L., et al. (2004). Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. The American Journal of Cardiology, 94(1), 92–95.PubMedCrossRef

62.

Herreros, J., et al. (2003). Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. European Heart Journal, 24(22), 2012–2020.PubMedCrossRef

63.

Menasche, P., et al. (2003). Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. Journal of the American College of Cardiology, 41(7), 1078–1083.PubMedCrossRef

64.

Murry, C. E., Field, L. J., & Menasche, P. (2005). Cell-based cardiac repair: Reflections at the 10-year point. Circulation, 112(20), 3174–3183.PubMedCrossRef

65.

Pagani, F. D., et al. (2003). Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. Journal of the American College of Cardiology, 41(5), 879–888.PubMedCrossRef

66.

Siminiak, T., et al. (2004). Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: Phase I clinical study with 12 months of follow-up. American Heart Journal, 148(3), 531–537.PubMedCrossRef

67.

Sung, N. S., et al. (2003). Central challenges facing the national clinical research enterprise. JAMA, 289(10), 1278–1287.PubMedCrossRef

68.

Wollert, K. C., et al. (2004). Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet, 364(9429), 141–148.PubMedCrossRef

69.

Hotta, A., & Ellis, J. (2008). Retroviral vector silencing during iPS cell induction: An epigenetic beacon that signals distinct pluripotent states. Journal of Cellular Biochemistry, 105(4), 940–948.PubMedCrossRef

70.

Maherali, N., et al. (2007). Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell, 1(1), 55–70.PubMedCrossRef

71.

Woltjen, K., et al. (2009). Piggybac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature, 27, 559–567.

72.

Laflamme, M. A., & Murry, C. E. (2005). Regenerating the heart. Nature Biotechnology, 23(7), 845–856.PubMedCrossRef

73.

Dengler, J., & Radisic, M. (2007). Tissue engineering approaches for the development of a contractile cardiac patch. Future Cardiology, 3(4), 425–434.PubMedCrossRef

74.

Shimizu, T., et al. (2009). Cell sheet-based myocardial tissue engineering: New hope for damaged heart rescue. Current Pharmaceutical Design, 15(24), 2807–2814.PubMedCrossRef

75.

Zimmermann, W. H., et al. (2006). Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nature Medicine, 12(4), 452–458.PubMedCrossRef

76.

Song, H., et al. (2010). Interrogating functional integration between injected pluripotent stem cell-derived cells and surrogate cardiac tissue. Proceedings of the National Academy of Sciences of the United States of America, 107(8), 3329–3334.PubMedCrossRef

77.

Song, H., Zandstra, P. W., and Radisic, M. (2011). Engineered Heart Tissue Model of Diabetic Myocardium. Tissue Eng Part A.

Title: Stem Cell-Based Cardiac Tissue Engineering
Authors: Sara S. Nunes
Hannah Song
C. Katherine Chiang
Milica Radisic
Publication date: 01-10-2011
Publisher: Springer US
Published in: Journal of Cardiovascular Translational Research / Issue 5/2011
Print ISSN: 1937-5387
Electronic ISSN: 1937-5395
DOI: https://doi.org/10.1007/s12265-011-9307-x

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Stem Cell-Based Cardiac Tissue Engineering

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2011

A Clinical Commentary on the Article “Biomaterials Advances in Patches for Congenital Heart Defect Repair”

A Clinical Commentary on the Article “N-acetylglucosamine Conjugated to Nanoparticles Enhances Myocyte Uptake and Improves Delivery of a Small Molecule p38 Inhibitor for Post-infarct Healing”

Patient-to-Patient Variability in Autologous Pericardial Matrix Scaffolds for Cardiac Repair

Biomaterials to Prevascularize Engineered Tissues

A Clinical Commentary on the Article “An Early Study on the Mechanisms that Allow Tissue-Engineered Vascular Grafts to Resist Intimal Hyperplasia”

N-acetylglucosamine Conjugated to Nanoparticles Enhances Myocyte Uptake and Improves Delivery of a Small Molecule p38 Inhibitor for Post-infarct Healing

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page